In the last trading session, 1.13 million Microbot Medical Inc (NASDAQ:MBOT) shares changed hands as the company’s beta touched 1.40. With the company’s per share price at $1.66 changed hands at $0.12 or 7.79% during last session, the market valuation stood at $57.68M. MBOT’s last price was a discount, traded about -103.61% off its 52-week high of $3.38. The share price had its 52-week low at $0.82, which suggests the last value was 50.6% up since then. When we look at Microbot Medical Inc’s average trading volume, we note the 10-day average is 0.79 million shares, with the 3-month average coming to 4.13 million.
Analysts gave the Microbot Medical Inc (MBOT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MBOT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Microbot Medical Inc’s EPS for the current quarter is expected to be -0.18.
Microbot Medical Inc (NASDAQ:MBOT) trade information
Instantly MBOT was in green as seen at the end of in last trading. With action 21.17%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 48.21%, with the 5-day performance at 21.17% in the green. However, in the 30-day time frame, Microbot Medical Inc (NASDAQ:MBOT) is -23.15% down. Looking at the short shares, we see there were 5.02 million shares sold at short interest cover period of 1.51 days.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 15.28%. The 2025 estimates are for Microbot Medical Inc earnings to increase by 26.76%.
MBOT Dividends
Microbot Medical Inc is expected to release its next quarterly earnings report on 2024-Nov-12.
Microbot Medical Inc (NASDAQ:MBOT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.62% of Microbot Medical Inc shares while 7.47% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.60%. There are 7.47% institutions holding the Microbot Medical Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 3.2694% of the shares, roughly 0.46 million MBOT shares worth $0.47 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 0.9773% or 0.14 million shares worth $0.14 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . With 348.55 shares estimated at $0.58 million under it, the former controlled 1.00% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.31% of the shares, roughly 108.03 shares worth around $0.18 million.
